Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Adagio Therapeutics, Inc. (ADGI)  
$2.51 0.15 (6.36%) as of 4:30 Tue 5/7


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 111,250,000
Market Cap: 279.24(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $1.05 - $5.04
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Invivyd is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of differentiated products for the prevention and treatment of infectious disease. Co. is developing its primary product candidate, adintrevimab, for the prevention and treatment of coronavirus disease 2019 (COVID-19), the disease caused by the virus SARS-CoV-2 and its variants. Adintrevimab is designed to be a neutralizing antibody for both the prevention and treatment of COVID-19. Co. is also evaluating additional neutralizing antibodies targeting the receptor binding domain, as well as other subdomains within the spike protein for COVID-19.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 2,858,000
Total Buy Value $0 $0 $0 $12,230,840
Total People Bought 0 0 0 2
Total Buy Transactions 0 0 0 4
Total Shares Sold 0 5,000,000 5,000,000 5,000,000
Total Sell Value $0 $19,750,000 $19,750,000 $19,750,000
Total People Sold 0 1 1 1
Total Sell Transactions 0 1 1 1
End Date 2024-02-08 2023-11-07 2023-05-09 2022-05-09

   
Records found: 28
  Page 2 of 2  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Adimab, Llc 10% Owner   –       –       •   2021-08-05 3 IO $0.00 $0 D/D 0 1,985,295     -
   Russo Rene Director   –       •      –    2021-08-05 3 IO $0.00 $0 D/D 0 1,985,295     -
   Gerngross Tillman U. Chief Executive OfficerOfficer   •       •       •   2021-08-05 3 IO $0.00 $0 I/I 0 1,985,295     -

  28 Records found
  1  2    
  Page 2 of 2
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed